3rd International Conference on Alzheimer’s Disease & Dementia
August 31-September 02, 2015 Toronto, Canada

Theme: Diagnosis Approaches of Dementia and Alzheimers Disease

Dementia2015welcomes attendees, presenters, and exhibitors from all over the world to Toronto, Canada. We are delighted to invite you all to attend and register for the“3rd International Conference on Alzheimer’s disease and Dementia (Dementia2015)”which is going to be held during August 31 - September 02, 2015 Toronto, Canada.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world.We invite you to join us at the Dementia2015, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Dementia2015 organizing committee look forward to meeting you in Toronto, Canada. (Body Text First Indent)

For more details please visit- http://alzheimers-dementia.conferenceseries.com/

Importance & Scope:

Dementia is a general term that describes a group of symptoms-such as loss of memory, judgment, language, complex motor skills, and other intellectual function-caused by the permanent damage or death of the brain's nerve cells, or neurons.

Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation.

Globally, results of a recent meta-analysis suggest that 35.6 million people lived with dementia worldwide in 2010, with numbers expected to almost double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. In 2010, 58 percent of all people with dementia lived in countries with low or middle incomes, with this proportion anticipated to rise to 63 percent in 2030 and 71 percent in 2050.This number is expected to double by 2030 and more than triple by 2050 to 115 million.

In the United States alone, experts estimate that as many as five million people age 65 and older suffer from Alzheimer’s disease.   

Why inToronto, Canada?

According to the Canada government, an estimated 747,000 Canadians were living with Alzheimer's disease or other forms of dementia in 2011.

In Canada 72% of Alzheimer's sufferers are women and 62% of dementia cases are also women. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries.

Nearly 800,000 Canadians are currently living with Alzheimer’s disease or other forms of dementia. By 2031, that number will likely double.

In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year.

People with Dementia in Toronto

Figure 1: Statistical Analysis of People with Dementia in Toronto

People with Dementia in Canada

Figure 2: Statistical Analysis of People with Dementia in Canada

Toronto is Canada's largest city, the fourth largest in North America, and home to a diverse population of about 2.8 million people. It's a global center for business, finance, arts and culture and is consistently ranked one of the world's most livable cities. The Greater Toronto Area (GTA) is a modern multicultural urban center with something for everyone. Year round, the GTA offers a unique mix of historical attractions, seasonal celebrations, family fun and a safe, walkable downtown core.

Conference Highlights:

  • Fast Facts: Dementia
  • Dementia Causes, Concerns and Preventions
  • Managing Dementia
  • Dementia Medication
  • Clinical Trials & Case Study
  • New Drug Discovery: Animal Models and Translational Research
  • Managing Dementia
  • Dementia Medication
  • Clinical Trials & Case Study
  • Clinical Trials & Case Study

Why to attend???

Dementia-2015 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about their work. Dementia- 2015 will congregate renowned speakers, principal investigators, experts, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The conference will be comprised of sessions by world class experts in the field of neurology. In Euro Psychiatry Summit-2015, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

A Unique Opportunity for Advertisers and Sponsors at this International event:


Members Associated with Dementia

Canadian Consortium on Neurodegeneration in Aging (CCNA) it brings together 340 researchers from across the country.

Their research will focus on improving the quality of life of those already living with Alzheimer’s disease and other forms of dementia.

The consortium is supported with funding of $31.5 million over five years from the Government of Can­ada through the Canadian Institutes of Health Research and a group of 13 partners from the public and private sectors, including the Alzheimer Society of Canada and Fonds de recherche du Québec – Santé. Jewish General Hospital (Montreal)

  • University of Ottawa
  • Mount Sinai Hospital-TORONTO
  • University of Alberta
  • McGill University
  • The Canadian Institutes of Health Research
  • Canadian Consortium on Neurodegeneration in Aging (CCNA)

Hospitals Associated with Dementia

About 200 Organizations Providing Dementia Services in Toronto

  • Mount Sinai
  • A.G.E. Matters Clinic
  • Ability Heath Care Supplies
  • Comforcare Toronto Central
  • Craig lee Nursing Home
  • Distress Centers of Toronto
  • Eatonville Care Centre
  • Eldercare Home Health Inc.
  • Fairview Nursing Home

Alzheimer Association & Societies around the Globe

  • Alzheimer's Australia
  • Albanian Alzheimer Society
  • Asociación de Lucha contra el Mal de Alzheimer
  • Asociación de Lucha contra el Mal de Alzheimer
  • Fundacion Alzheimer Aruba (FAA)
  • Alzheimer's Australia
  • Alzheimer Austria
  • Alzheimer Support Group
  • Alzheimer Society of Bangladesh
  • Barbados Alzheimer's Association Inc.
  • Alzheimer’s and Dementia Association of The Cayman Islands
  • Ligue National Alzheimer Liga
  • Alzheimer's Family Support Group
  • Asociación Boliviana de Alzheimer y Otras Demencias
  • FEBRAZ - Federação Brasileira de Associaçãoes de Alzheimer
  • Corporation Alzheimer Chile
  • Alzheimer's disease Chinese

Alzheimer Association & Societies in Canada

  • Alzheimer Society of Ontario
  • Alzheimer's disease International
  • Dementia Networks across Ontario
  • Alzheimer's Education and Referral Center
  • Alzheimer Research Forum
  • Alzheimer Knowledge Exchange
  • Murray Alzheimer Research and Education Program (MAREP) University of Waterloo

Universities in Canada:

  • University of Toronto
  • University of British Columbia
  • University of Alberta
  • Simon Fraser University
  • University of Waterloo
  • McGill University
  • University of Calgary
  • Queen’s University
  • York University
  • University of Victoria

Universities associated with dementia in globally

Figure 4:Universities associated with dementia


Target Audience:

Neurologists and Directors, Physicians, Neuroscientists, Specialists, researchers, health care professionals, Professors, Lecturers and Students from Academia in the study of Dementia

Market Value and Growth on Dementia:

  • Economic cost of dementia in Canada 2011 $33 billion
  • Globally, dementia cost $600 billion in a year
  • In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year
  • From 2003-2013 CIHR funding for dementia research was $236 million
  • The Pfizer drug dominates sales, with about $ 4 billion annually

Aricept (Donepezil-generic) (Pfizer)

  • Ranbaxy market size of Aricept (Donepezil Hydrochloride) in Canada is $ 153.9 million
  • Razadyne (Johnson & Johnson) market size is $ 5.3 billion
  • Exelon (Novartis)
  • Namenda (Forest Laboratories) spending for dementia research was $236 million

Products manufactured by the industries

Three drugs are available in Canada to treat symptoms in people with Mild to moderate Alzheimer’s disease

Aricept™ produced by Pfizer Canada Inc.,

Exelon™ produced by Novartis Pharma Canada Inc.

Reminyl™ produced by Janssen Ortho Inc.

Two drugs for Moderate to advanced Alzheimer’s disease



Alzheimer’s disease and Dementia in numbers...

Fund Allotment to Dementia

National dementia research initiative gets $31.5M funding from the federal government and several partners, as well as an additional, separate $24 million from partners in Ontario and Quebec. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year.


  1. http://www.cihr-irsc.gc.ca/e/45554.html
  2. http://www.providencecare.ca/clinical-tools/Documents/Ontario-Dementia-Projections-2010.pdf
  3. http://www.concordia.ca/cunews/main/stories/2014/09/16/revolutionizing-alzheimersresearchincanada.htm
  4. http://www.dementiatoronto.org/allagencies.asp
  5. http://www.cbc.ca/news/health/national-dementia-research-intitiative-gets-31-5m-federal-funding-1.2762253
  6. http://seekingalpha.com/article/2042953-following-the-latest-in-alzheimers-research-as-an-investor
  7. http://www.alzheimer.ca/en/Living-with-dementia/Treatment-options/Drugs-approved-for-Alzheimers-disease
  8. http://news.gc.ca/web/article-en.do;jsessionid=a0a6a2037001e091ddee53f66c5dc11c8e26df830028d1e9d682dde6c1b6ecd8.e38RbhaLb3qNe38Kbxj0?mthd=tp&crtr.page=3&nid=883019&crtr.tp1D=1
  9. http://www.jghfoundation.org/sections/vpadd.html

Select your language of interest to view the total content in your interested language
Share This Article
Browse Conferences
2014 Conferences
2015 Conferences
Region-wise Conferences
Conference Destination Map
Previous Conferences
Subject wise
Open Access Journals
Clinical Journals
Chemistry Journals
Engineering Journals
Environmental Journals
Life Sciences Journals
Management Journals
Medical Sciences Journals
OMICS Journals
Pharmaceutical Sciences Journals
Follow Us   RSS  Facebook  Twitter  Blog  Linkedin  You tube  Google Plus  Pintrest  Flickr  Slide Share
About Us | Open Access | Open Access Journals | OMICS Group Conferences | International Collaborations | Scientific Credits | Membership | Submit Manuscript | OMICS Publishing Group
Manuscript Submission & Tracking System | Open Access Publishing | Open Access Publication
Copyright © 2014 OMICS Group, All Rights Reserved.